NYSE:TJX

The TJX Companies, Inc. (NYSE: TJX) Reports Strong First-Quarter Earnings and Revenue

Font: Financial Modeling Prep  • May 20, 2026

Market Chart
  • The TJX Companies, Inc. (NYSE: TJX) exceeded analyst expectations with strong first-quarter earnings per share (EPS) of $1.19 and total revenue of $14.32 billion.
  • The off-price retail giant saw robust growth, including a 6% increase in comparable sales and a notable 9% growth in its HomeGoods division.
  • Demonstrating confidence in future performance, TJX raised its full fiscal year EPS guidance to between $5.08 and $5.15 and increased its share buyback program.

Before the market opened, The TJX Companies, Inc. (NYSE: TJX) announced strong first-quarter results. This major off-price retailer operates popular stores like T.J. Maxx and Marshalls, selling brand-name products at discounted prices. This business model attracts shoppers looking for value.

The company reported an earnings per share (EPS) of $1.19. This figure represents the company's profit divided by its number of outstanding shares. As highlighted by Zacks, this result surpassed the analyst consensus estimate of $1.01 and marks a significant 29% increase from the $0.92 per share earned a year ago.

TJX also announced total revenue of $14.32 billion for the quarter. This beat the estimated $14.02 billion and shows a 9% increase from the $13.11 billion reported in the same period last year. This is the fourth straight quarter that TJX has exceeded estimates for both earnings and revenue.

This growth was driven by a 6% increase in comparable sales, which measures sales at stores open for at least a year. The HomeGoods division showed particularly strong performance with a 9% growth in sales. The company also reported a healthy pretax profit margin of 12.0% for the quarter.

Following these results, TJX has raised its guidance for the full fiscal year. It now expects an EPS between $5.08 and $5.15. The company also increased its outlook for sales growth and its share buyback program, signaling confidence in its future performance.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.26
40.79%
SBFM
Sunshine Biopharma, Inc.
$0.49
32.15%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.59
0.59%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.80
-0.62%
NVDA
NVIDIA Corporation
$219.50
-1.78%
WOK
WORK Medical Technology Group Ltd.
$0.16
-17.67%
CXAI
CXApp Inc.
$0.21
20.11%
RGTI
Rigetti Computing, Inc.
$21.11
25.05%
NIVF
NewGenIvf Group Limited
$1.07
44.77%
CODX
Co-Diagnostics, Inc.
$3.75
56.69%